Sort
21,453 grants matching “tuberculosis”
Exploiting new drug targets in extremely resistant M.abscessus by using small molecule Lipid II binders
$161,264Yutaka Tagaya · University Of Maryland Baltimore · R21 · FY2022 · AI
Using an implementation science approach to refine, implement and evaluate pilot strategies for tuberculosis contact tracing in South Africa
$161,258Colleen Hanrahan · Johns Hopkins University · K01 · FY2023 · HL
NRAMP1 IN MACROPHAGE DEFENCES AGAINST INFECTIONS
$161,190Mcgill University · R01 · FY2001 · AI
mHealth-assisted conditional cash transfers to improve timeliness of vaccinations
$161,098Jan Ostermann · Duke University · R21 · FY2017 · TW
Humoral immunity against the M. tuberculosis kasB persistent mutant
$161,080John R. Chan · Albert Einstein College Of Medicine · R21 · FY2018 · AI
TB- FISH Assay for Direct Detection of M. tuberculosis in unprocessed sputum
$161,020Jyotsna S Shah · Id Fish Technology, Inc. · R43 · FY2007 · AI
A SYSTEMS APPROACH TO DEVELOP IMPROVED BOVINE TUBERCULOSIS MITIGATION STRATEGIES
$161,006Regents Of The University Of Minnesota · · FY2010 · National Institute of Food and Agriculture
BOVINE TUBERCULOSIS MI/MN
$161,005Michigan State University · · FY2010 · National Institute of Food and Agriculture
Overcoming restrained lung trafficking by memory CD4+ T cells to prevent active tuberculosis in people living with HIV
$161,000Stephen Matthew Carpenter · Case Western Reserve University · R21 · FY2023 · AI
Cough - A Rapid Indicator of Response to Therapy in Pulmonary Tuberculosis
$160,972Robert H Gilman · Johns Hopkins University · R21 · FY2013 · AI
Checkpoints of TNF Gene Regulation
$160,764Anne Goldfeld · Immune Disease Institute, Inc. · R01 · FY2012 · GM
Investigating platelets in the innate immune response to tuberculosis
$160,738Robert H Gilman · Johns Hopkins University · R21 · FY2020 · AI
PARACAS: Program for Advanced Research Capacities for AIDS in Peru
$160,720Eduardo Gotuzzo · Universidad Peruana Cayetano Heredia · D43 · FY2018 · TW
Nramp1 in macrophage defences against infections
$160,650Mcgill University · R01 · FY2005 · AI
Molecular Pathogenesis of Infectious Diseases
$160,649Linda F Van Dyk · University Of Colorado Denver · T32 · FY2022 · AI
Rifabutin pharmacokinetics and safety among HIV/TB coinfected infants receiving lopinavir
$160,625Holly Elizabeth Rawizza · Brigham And Women'S Hospital · R21 · FY2020 · AI
Microbiology, Immunology, Animal Modeling and Imaging
$160,622William Ramses Bishai · Johns Hopkins University · P30 · FY2025 · AI
Spatial approaches for optimizing TB active case finding: an investigation of activity spaces, mobility patterns, and local burden of disease in Nairobi, Kenya
$160,576Khai Hoan Vu Tram · University Of Washington · K01 · FY2025 · AI
Administrative Core
$160,503Eric Joseph Rubin · Harvard School Of Public Health · U19 · FY2015 · AI
Directly observed antiretroviral therapy in drug abusers
$160,456Johns Hopkins University · K23 · FY2005 · DA
Smartphone ultrasonography to improve diagnosis and treatment of life-threatening injuries for trauma patients in Cameroon
$160,298Sabrinah Ariane Christie · University Of California Los Angeles · R21 · FY2024 · TW
Multidisciplinary Clinical Research and Mentoring in Tuberculosis Diagnostics
$160,284Susan E Dorman · Johns Hopkins University · K24 · FY2015 · AI
Triacylglycerol metabolism and Mtb virulence
$160,266Lanbo Shi · Rbhs-New Jersey Medical School · R21 · FY2012 · AI
Using an implementation science approach to refine, implement and evaluate pilot strategies for tuberculosis contact tracing in South Africa
$160,257Colleen Hanrahan · Johns Hopkins University · K01 · FY2024 · HL
Drug permeation and activity in Mycobacterium tuberculosis infected macrophages
$160,246Digby Francis Warner · University Of Cape Town · R21 · FY2015 · AI